phenoxazine has been researched along with 3-aminophenoxazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, A; Akiyama, S; Che, XF; Imaizumi, K; Kato, S; Mizuguchi, J; Odawara, M; Shirato, K; Tomoda, A; Toyota, H | 1 |
| Aoyagi, H; Endo, T; Hanami, M; Ikegami, K; Kurosaki, K; Miyano-Kurosaki, N; Tomoda, A; Yasumoto, J | 1 |
2 other study(ies) available for phenoxazine and 3-aminophenoxazone
| Article | Year |
|---|---|
Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Humans; Membrane Glycoproteins; Molecular Structure; Oxazines; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2006 |
Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Giant Cells; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Indicators and Reagents; Necrosis; Oxazines; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm | 2009 |